Progression-free survival in patients in with advanced ovarian cancer defined by GCIG criteria vs. RECIST criteria: Analysis of the secondary endpoint of the AGO-Ovar16 trial

S. Mahner, C. Jackisch, J. Sehouli,J. Rau, B. Schmalfeldt, A. Belau,B. Richter, G. Emons, T. -W. Park-Simon,H. -J. Lueck, A. Burges, T. Fehm, G. Feisel-Schwickardi, M. Clemens,A. du Bois

ONCOLOGY RESEARCH AND TREATMENT(2014)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要